MS Pharma And Hetero Team Up On Biosimilars In Algeria

Manufacturing Localization Deal Covers Five ‘Established’ Biosimilars

 
• By Dave Wallace
  
MS Pharma’s El Kendi has struck a localization deal with Hetero Biopharma (Shutterstock)

More from Deals

More from Business